Medication info
SimvaRoad Tablets 40 mg (Simvastatin)

SimvaRoad Tablets 40 mg (Simvastatin)

Prescription medicationTabletOral
Ingredient · strength
Simvastatin›40mg / 1 tablet
Manufacturer / importer
Jongkundang Co., Ltd.
Appearance
Red brick-colored rectangular film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200400121 · Notified 2004.09.03 · Insurance code 643301490

Summary

Main use
Improvement of hyperlipidemia (including pediatric heterozygous familial hyperlipidemia); prevention of cardiovascular disease
Who takes it
Adults · Children
Adult dose
Patients receiving this medicine before and during treatment must follow a standard cholesterol-lowering diet. 1. Reduction of cardiovascular risk Adult patients at high risk of coronary heart disease events because of coronary heart disease, diabetes, peripheral vascular disease, a history of stroke, or other cerebrovascular disease The recommended initial dose is simvastatin 40 mg once daily. 2. Hyperlipidemia 1) Risk reduction in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended initial dose is 20 mg of this medicine once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this medicine. A dose of 5 ~ 40 mg of this medicine once daily in the evening is recommended. Adjust the dose appropriately according to the initial LDL cholesterol level before treatment, the treatment goal, and the patient's response to the medicine. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter, and adjust the dose. Reduce the dose if the cholesterol level falls below the target level. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 80 mg dose of this medicine should be used only in patients who have taken 80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). 2) Refer to the information below for recommended doses in patients receiving this medicine concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in specific patient groups (i.e., patients with homozygous familial hypercholesterolemia, older adults, and patients with renal impairment) (see 6. Interactions under Precautions for Use). (1) Administration to patients with homozygous familial hypercholesterolemia Based on the results of controlled clinical trials, administer 40 mg of this medicine once daily in the evening to patients with homozygous familial hypercholesterolemia. Administer this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not possible. (2) In older adults, the maximum cholesterol-lowering effect may be achieved with a daily dose of 20 mg of this medicine. (3) Administration to patients receiving verapamil, diltiazem, or dronedarone When this medicine is coadministered to patients receiving verapamil, diltiazem, or dronedarone, the dose of this medicine must not exceed 10 mg daily. (4) Administration to patients receiving amiodarone, amlodipine, or ranolazine When this medicine is coadministered to patients receiving amiodarone, amlodipine, or ranolazine, the dose of this medicine must not exceed 20 mg daily. (5) Concomitant administration with other lipid-lowering agents This medicine is effective when administered alone or in combination with a bile acid sequestrant. When this medicine is coadministered with a fibrate (excluding gemfibrozil (see 2. Patients Who Must Not Receive This Medicine under Precautions for Use) and fenofibrate), the dose of this medicine must not exceed 10 mg daily. (6) Administration to patients with renal impairment Because this medicine is not extensively excreted by the kidneys, no dose adjustment is necessary in patients with mild to moderate renal impairment. In patients with severe renal impairment, however, initiate treatment at 5 mg daily and monitor carefully.
Child dose
Pediatric patients aged 10 ~ 17 years with heterozygous familial hypercholesterolemia: The recommended initial dose is 10 mg of this medicine once daily in the evening. The recommended dose range is 10 ~ 40 mg daily, and the recommended maximum dose is 40 mg daily. Adjust the dose appropriately for each patient according to the recommended treatment goal. Allow an interval of 4 weeks or more between dose adjustments.

Ingredients

Manufacturer
Jongkundang Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia (including pediatric heterozygous familial hyperlipidemia); prevention of cardiovascular disease

  • Coronary heart disease
  • diabetes
  • peripheral vascular disease
  • stroke
  • other cerebrovascular diseases
  • hypercholesterolemia
  • dyslipidemia
  • dysbetalipoproteinemia
  • hypertriglyceridemia
  • heterozygous familial hypercholesterolemia
View approved original text

This medication is used to reduce the risk of cardiovascular disease. It is administered to adult patients at high risk for coronary events due to coronary heart disease, diabetes, peripheral vascular disease, or stroke, reducing the risk of mortality from coronary heart disease as well as the risks of non-fatal myocardial infarction and stroke. Additionally, it effectively lowers the risk of complications after vascular revascularization. As a treatment for hyperlipidemia, it lowers cholesterol and triglyceride levels in patients with primary hypercholesterolemia and mixed dyslipidemia while increasing the levels of good cholesterol, HDL. Furthermore, it is beneficial for pediatric patients with heterozygous familial hypercholesterolemia who have difficulties managing lipid levels through diet alone.

How to take

Adult dose

Patients receiving this medicine before and during treatment must follow a standard cholesterol-lowering diet. 1. Reduction of cardiovascular risk Adult patients at high risk of coronary heart disease events because of coronary heart disease, diabetes, peripheral vascular disease, a history of stroke, or other cerebrovascular disease The recommended initial dose is simvastatin 40 mg once daily. 2. Hyperlipidemia 1) Risk reduction in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended initial dose is 20 mg of this medicine once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this medicine. A dose of 5 ~ 40 mg of this medicine once daily in the evening is recommended. Adjust the dose appropriately according to the initial LDL cholesterol level before treatment, the treatment goal, and the patient's response to the medicine. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter, and adjust the dose. Reduce the dose if the cholesterol level falls below the target level. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 80 mg dose of this medicine should be used only in patients who have taken 80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). 2) Refer to the information below for recommended doses in patients receiving this medicine concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in specific patient groups (i.e., patients with homozygous familial hypercholesterolemia, older adults, and patients with renal impairment) (see 6. Interactions under Precautions for Use). (1) Administration to patients with homozygous familial hypercholesterolemia Based on the results of controlled clinical trials, administer 40 mg of this medicine once daily in the evening to patients with homozygous familial hypercholesterolemia. Administer this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not possible. (2) In older adults, the maximum cholesterol-lowering effect may be achieved with a daily dose of 20 mg of this medicine. (3) Administration to patients receiving verapamil, diltiazem, or dronedarone When this medicine is coadministered to patients receiving verapamil, diltiazem, or dronedarone, the dose of this medicine must not exceed 10 mg daily. (4) Administration to patients receiving amiodarone, amlodipine, or ranolazine When this medicine is coadministered to patients receiving amiodarone, amlodipine, or ranolazine, the dose of this medicine must not exceed 20 mg daily. (5) Concomitant administration with other lipid-lowering agents This medicine is effective when administered alone or in combination with a bile acid sequestrant. When this medicine is coadministered with a fibrate (excluding gemfibrozil (see 2. Patients Who Must Not Receive This Medicine under Precautions for Use) and fenofibrate), the dose of this medicine must not exceed 10 mg daily. (6) Administration to patients with renal impairment Because this medicine is not extensively excreted by the kidneys, no dose adjustment is necessary in patients with mild to moderate renal impairment. In patients with severe renal impairment, however, initiate treatment at 5 mg daily and monitor carefully.

Child dose

Pediatric patients aged 10 ~ 17 years with heterozygous familial hypercholesterolemia: The recommended initial dose is 10 mg of this medicine once daily in the evening. The recommended dose range is 10 ~ 40 mg daily, and the recommended maximum dose is 40 mg daily. Adjust the dose appropriately for each patient according to the recommended treatment goal. Allow an interval of 4 weeks or more between dose adjustments.

Precautions

This medication can cause serious side effects such as myopathy or rhabdomyolysis, leading to muscle abnormalities. The risk is particularly higher with high doses, so patients taking high doses should be cautious of drug interactions. This medication should not be taken by patients with a known allergy to this drug or its components, severe liver dysfunction, or by women who are pregnant or breastfeeding. Additionally, it is contraindicated to use in combination with certain strong hepatic enzyme inhibitors and some other medications. Patients with liver dysfunction or those who consume large amounts of alcohol, individuals with poor kidney function, hypothyroidism, a history of muscle diseases, older adults, and women should use this medication with caution. If unexplained muscle pain or weakness occurs while taking this medication, the physician should be informed immediately, and the medication should be discontinued if necessary. It is vital to perform regular liver function tests before and during treatment as this medication can cause liver dysfunction. Moreover, this medication can interact with multiple drugs, potentially increasing blood concentration, therefore consulting a physician or pharmacist about other medications taken concurrently is essential. It should be avoided during pregnancy, and women of childbearing age should use contraception while taking this medication. Nursing mothers should discontinue breastfeeding if they take this medication. It is recommended not to prescribe this medication to children or adolescents, especially those under 10 years old or females before menarche. Older adults may experience higher blood concentration of this drug, hence dosage adjustment and careful monitoring is necessary. During treatment, symptoms related to muscles, liver function, allergic reactions, gastrointestinal symptoms, etc., should be closely observed, and if any abnormal symptoms occur, medical personnel must be notified immediately. In case of overdose, emergency care is required. Lastly, this medication should be kept out of the reach of children and stored safely in its original container.

Side effects

  • Myopathy
  • rhabdomyolysis
  • abdominal pain
  • weakness
  • constipation
  • diarrhea
  • dyspepsia
  • bloating
  • nausea
  • headache
Show 93 more
  • upper respiratory infection
  • edema
  • atrial fibrillation
  • gastritis
  • diabetes
  • myalgia
  • insomnia
  • dizziness
  • bronchitis
  • sinusitis
  • eczema
  • urinary tract infection
  • muscle cramps
  • arthralgia
  • dysgeusia
  • oculomotor dysfunction
  • facial paresis
  • tremor
  • sensory disturbance
  • peripheral neuropathy
  • peripheral nerve paralysis
  • mental disorder
  • anxiety
  • sleep disorder
  • nightmares
  • depression
  • cognitive impairment
  • myasthenia gravis
  • ocular myasthenia
  • hepatitis
  • liver dysfunction
  • jaundice
  • pancreatitis
  • liver failure
  • cholestatic jaundice
  • hepatic steatosis
  • liver cirrhosis
  • fulminant hepatic necrosis
  • liver cancer
  • loss of appetite
  • vomiting
  • alopecia
  • pruritus
  • skin changes
  • lichenoid drug eruption
  • gynecomastia
  • decreased libido
  • sexual dysfunction
  • cataract progression
  • ophthalmoplegia
  • anemia
  • elevated aminotransferases
  • elevated ALP
  • elevated γ-GTP
  • elevated bilirubin levels
  • thyroid dysfunction
  • elevated serum creatine kinase
  • interstitial lung disease
  • anaphylaxis
  • angioedema
  • lupus-like syndrome
  • polymyositis
  • dermatomyositis
  • vasculitis
  • purpura
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • positive antinuclear antibody
  • increased erythrocyte sedimentation rate
  • eosinophilia
  • arthritis
  • urticaria
  • phototoxicity
  • fever
  • chills
  • flushing
  • malaise
  • dyspnea
  • toxic epidermal necrolysis
  • mucous membrane syndrome
  • erythema multiforme
  • peripheral sensory numbness
  • tingling
  • cold sensation
  • muscle weakness
  • thrombocytopenia
  • interstitial lung disease
  • memory decline
  • forgetfulness
  • memory loss
  • memory impairment
  • confusion

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly sealed container to prevent exposure to air or moisture. It is important to maintain a storage temperature between 1 to 30 degrees Celsius to preserve the medication's effectiveness and safety over time.

Appearance and packaging

Appearance

Red brick-colored rectangular film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.